Clinical Trial Update: A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating obinutuzumab and chlorambucil (GC) chemotherapy for elderly chronic lymphocytic leukemia patients, with NGS-based assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Chlorambucil (chlorambucil)
• Obinutuzumab (obinutuzumab)

Snippet

Sponsor: Deok-Hwan Yang | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: UNKNOWN